In Denmark kidney transplantation is more cost-effective than dialysis

Danish Medical Journal

Volumn 61, Issue 3, 2014, Pages

  Elgaard Jensen, Cathrine ^a   Sørensen, Preben ^b,c   Dam Petersen, Karin ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Dansk Center for Organdonation   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEATH; DENMARK; DIALYSIS; HEALTH CARE COST; HIDDEN MARKOV MODEL; HUMAN; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATION; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SIMULATION; TREATMENT OUTCOME;

EID: 84895508305     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dansk Nefrologisk Selskabs Landsregister. Årsrapport 2012. Denmark: Dansk Nefrologisk Sekskab, 2013.
2. scandiatransplant.org. Scandiatransplant figures www.scandiatransplant. org/data/scandiatransplant-figures (9 Sep 2013).
3. Drummond MF, Sculpher MJ, Torrance GW et al. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press Inc, 2005.
4. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
5. Cheung K, Oemar M, Oppe M et al. EQ-5D user guide: basic information on how to use EQ-5D. Version 2. Rotterdam: EuroQol Group, 2009.
6. Ministeriet for Sundhed og Forebyggelse. Takstsystemet 2012 - vejledning. Copenhagen: Ministeriet for Sundhed og Forebyggelse, 2012.
7. Statens Serum Institut. Interaktiv DRG http://drgservice.ssi.dk/grouper/ Modules/Home/ (11 Sep 2013).
8. www.rigshospitalet.dk/menu/AFDELINGER/Abdominalcentret/ Nefrologisk+Klinik/Sygdom+og+behandling/Dialyse/ (16 Sep 2013).
9. Rigshospitalet. Information om nyretransplantation. http://regionh.play. webfighter.dk/Web Arkiv/Rigshospitalet/Abdominalcentret/Nefrologisk Klinik/RH_ABD_NEFRO_Information_om_nyretransplantation_Print.pdf (Oct 2012).
10. Kho M, Cransberg K, Weimar W et al. Current immunosuppressive treatment after kidney transplantation. Expert Opinion on Pharmacotherapy 2011;12:1217-31.
11. Prescilla RP. Immunosuppression: small-molecule immunosuppressive drugs. Medscape. http://emedicine.medscape.com/article/1013392-overview#aw2aab6b5 (Sep 2013).
12. Statens Serum Institut. Dataleverancer og lægemiddelstatistik. http://medstat.dk (28 Jun 2013)
13. Dansk Laegemiddel Information A/S. http://pro.medicin.dk (28 Jun 2013).
14. Sennfält K, Magnusson M, Carlsson P. Comparison of hemodialysis and peritoneal dialysis - a cost-utility analysis. Peritoneal Dialysis Int 2002;22:39-47.
15. Dansk Nefrologisk Selskabs Landsregister. Årsrapport 2011. Dansk Nefro-logisk Selskab, 2012.
16. Lægemiddelstyrelsen. Medicintilskudsgrænser 2012 http://laegemiddelstyrelsen.dk/da/topics/statistik,-priser-og-tilskud/ tilskud-til-medicin/tilskudsgraenser (8 May 2012).
17. Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. In: Gray A, Briggs A, editors. 1st ed. Making decision models probalistic. New York: Oxford University Press Inc; 2006:77-118.
18. Jarl J, Gerdtham U-G. Economic evaluations of organ transplantations - a systematic literature review. Nord J Health Econ 2011;1:64-7.
19. Messa P, Ponticelli C, Berardinelli L. Coming back to dialysis after kidney transplant failure. Nephrol Dial Transplant 2008;23:2738-42.
20. Tiessen J, Conklin A, Janta B et al. Improving organ donation and transplantation in the European Union - assessing the impacts of European action. RAND Corporation, 2008. www.rand.org/pubs/ technical_reports/TR602.html (19 Sep 2012).